Terms: = Pancreatic cancer AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b
62 results:
1. Myofibroblastic cancer-associated fibroblast subtype heterogeneity in pancreatic cancer.
Kearney JF; Trembath HE; Chan PS; Morrison AB; Xu Y; Luan CF; McCabe IC; Zarmer SA; Kim HJ; Peng XL; Yeh JJ
J Surg Oncol; 2024 Apr; 129(5):860-868. PubMed ID: 38233984
[TBL] [Abstract] [Full Text] [Related]
2. cancer-Associated Fibroblasts Promote Lymphatic Metastasis in Cholangiocarcinoma via the PDGF-BB/pdgfr-β Mediated Paracrine Signaling Network.
Yan J; Xiao G; Yang C; Liu Q; Lv C; Yu X; Zhou Z; Lin S; Bai Z; Lin H; Zhang R; Liu C
Aging Dis; 2024 Feb; 15(1):369-389. PubMed ID: 37307823
[TBL] [Abstract] [Full Text] [Related]
3. FOXA2 plays a critical role in hepatocellular carcinoma progression and lenvatinib-associated drug resistance.
Wang Z; Shen J; Chen C; Wen T; Li C
Biosci Trends; 2023 May; 17(2):136-147. PubMed ID: 36823043
[TBL] [Abstract] [Full Text] [Related]
4. A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with pancreatic ductal adenocarcinoma.
van Eijck CWF; de Koning W; van der Sijde F; Moskie M; Groot Koerkamp B; Homs MYV; van der Burg SH; van Eijck CHJ; Mustafa DAM
Eur J Cancer; 2023 Mar; 181():119-134. PubMed ID: 36652890
[TBL] [Abstract] [Full Text] [Related]
5. Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies.
Yao C; Wu S; Kong J; Sun Y; Bai Y; Zhu R; Li Z; Sun W; Zheng L
Cancer Biol Med; 2023 Jan; 20(1):25-43. PubMed ID: 36647777
[TBL] [Abstract] [Full Text] [Related]
6. Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer.
Shi YH; Xu QC; Zhu YQ; Liu ZD; Zhao GY; Liu Q; Wang XY; Wang JQ; Xu X; Su Q; Lai JM; Huang CS; Yin XY
Mol Ther; 2023 Feb; 31(2):503-516. PubMed ID: 36384875
[TBL] [Abstract] [Full Text] [Related]
7. pancreatic ductal adenocarcinoma cells regulated the gemcitabine-resistance function of CAFs by LINC00460.
Zhu XX; Li JH; Ni X; Wu X; Hou X; Li YX; Li SJ; Zhao W; Yin XY
Cancer Sci; 2022 Nov; 113(11):3735-3750. PubMed ID: 36047966
[TBL] [Abstract] [Full Text] [Related]
8. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the Treatment of cancer: A Review.
Unnisa A; Chettupalli AK; Hussain T; Kamal MA
Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
[TBL] [Abstract] [Full Text] [Related]
9. Determining oncogenic patterns and cancer predisposition through the transcriptomic profile in Mitchell-Riley syndrome with heterotopic gastric mucosa and duodenal atresia: a case report.
Calcaterra V; Chiricosta L; Mazzon E; Gugnandolo A; Alberti D; Maestri L; Meroni M; Vestri E; Verduci E; Dilillo D; Zuccotti G; Pelizzo G
Orphanet J Rare Dis; 2021 Oct; 16(1):455. PubMed ID: 34715892
[TBL] [Abstract] [Full Text] [Related]
10. Establishment of a 3D model of tumor-driven angiogenesis to study the effects of anti-angiogenic drugs on pericyte recruitment.
Qiu Y; Wang N; Guo T; Liu S; Tang X; Zhong Z; Chen Q; Wu H; Li X; Wang J; Zhang S; Ou Y; Wang B; Ma K; Gu W; Cao J; Chen H; Duan Y
Biomater Sci; 2021 Sep; 9(18):6064-6085. PubMed ID: 34136892
[TBL] [Abstract] [Full Text] [Related]
11. pdgfr-β
Hu G; Huang L; Zhong K; Meng L; Xu F; Wang S; Zhang T
Aging (Albany NY); 2021 May; 13(10):13693-13707. PubMed ID: 33946048
[TBL] [Abstract] [Full Text] [Related]
12. Establishment and characterization of NCC-PLPS1-C1, a novel patient-derived cell line of pleomorphic liposarcoma.
Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2021 Mar; 34(2):688-697. PubMed ID: 33205363
[TBL] [Abstract] [Full Text] [Related]
13. Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results.
Ueno M; Ikeda M; Sasaki T; Nagashima F; Mizuno N; Shimizu S; Ikezawa H; Hayata N; Nakajima R; Morizane C
BMC Cancer; 2020 Nov; 20(1):1105. PubMed ID: 33198671
[TBL] [Abstract] [Full Text] [Related]
14. Establishment and characterization of NCC-MLPS1-C1: a novel patient-derived cell line of myxoid liposarcoma.
Noguchi R; Yoshimatsu Y; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2021 Mar; 34(2):667-674. PubMed ID: 33146842
[TBL] [Abstract] [Full Text] [Related]
15. Discovery of Prognostic Signature Genes for Overall Survival Prediction in Gastric cancer.
Meng C; Xia S; He Y; Tang X; Zhang G; Zhou T
Comput Math Methods Med; 2020; 2020():5479279. PubMed ID: 32908579
[TBL] [Abstract] [Full Text] [Related]
16. Design, synthesis, biological evaluation and molecular modeling study of new thieno[2,3-d]pyrimidines with anti-proliferative activity on pancreatic cancer cell lines.
Salem MSH; Abdel Aziz YM; Elgawish MS; Said MM; Abouzid KAM
Bioorg Chem; 2020 Jan; 94():103472. PubMed ID: 31813475
[TBL] [Abstract] [Full Text] [Related]
17. Targeting Purinergic Receptor P2Y2 Prevents the Growth of pancreatic Ductal Adenocarcinoma by Inhibiting cancer Cell Glycolysis.
Hu LP; Zhang XX; Jiang SH; Tao LY; Li Q; Zhu LL; Yang MW; Huo YM; Jiang YS; Tian GA; Cao XY; Zhang YL; Yang Q; Yang XM; Wang YH; Li J; Xiao GG; Sun YW; Zhang ZG
Clin Cancer Res; 2019 Feb; 25(4):1318-1330. PubMed ID: 30420446
[TBL] [Abstract] [Full Text] [Related]
18. Melatonin Synergizes with Sorafenib to Suppress pancreatic cancer via Melatonin Receptor and pdgfr-β/STAT3 Pathway.
Fang Z; Jung KH; Yan HH; Kim SJ; Rumman M; Park JH; Han B; Lee JE; Kang YW; Lim JH; Hong SS
Cell Physiol Biochem; 2018; 47(5):1751-1768. PubMed ID: 29953970
[TBL] [Abstract] [Full Text] [Related]
19. E4206: AMG 706 and Octreotide in Patients with Low-Grade Neuroendocrine Tumors.
Lubner S; Feng Y; Mulcahy M; O'Dwyer P; Giang GY; Hinshaw JL; Deming D; Klein L; Teitelbaum U; Payne J; Engstrom P; Stella P; Meropol N; Benson A
Oncologist; 2018 Sep; 23(9):1006-e104. PubMed ID: 29853660
[TBL] [Abstract] [Full Text] [Related]
20. Masitinib in treatment of pancreatic cancer.
Waheed A; Purvey S; Saif MW
Expert Opin Pharmacother; 2018 May; 19(7):759-764. PubMed ID: 29638149
[TBL] [Abstract] [Full Text] [Related]
[Next]
